PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT polarityte, inc.Polarityte, Inc. • March 17th, 2022 • Biological products, (no disgnostic substances)
THIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after September __, 2022 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on __________ __, 20__ (the “Termination Date”) but not thereafter, to subscribe for and purchase from PolarityTE, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is being issued pursuant to that certain engagement letter, dated as of March 5, 2022, by and between the Company and H.C. Wainwright & Co., LLC.
COMMON STOCK PURCHASE WARRANT polarityte, inc.Common Stock Purchase Warrant • March 17th, 2022 • Polarityte, Inc. • Biological products, (no disgnostic substances)
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after September __, 2022 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on __________ __, 20__ (the “Termination Date”) but not thereafter, to subscribe for and purchase from PolarityTE, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 17th, 2022 • Polarityte, Inc. • Biological products, (no disgnostic substances) • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of March 15, 2022, between PolarityTE, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
ContractPolarityte, Inc. • March 17th, 2022 • Biological products, (no disgnostic substances)
